SCHEMBL469221

SCHEMBL469221

CCc1cncs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28294062 0.91 SLC6A3 (0.40)
SCHEMBL6032061 0.80
SCHEMBL178406 0.75
SCHEMBL289897 0.74 HDAC8 (0.40)
Hydrochloric Acid SCHEMBL70364 0.74
SCHEMBL1274803 0.74
SCHEMBL507903 0.74
SCHEMBL14124538 0.74
SCHEMBL13067260 0.74
SCHEMBL177681 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0435151-A2 Process for the preparation of 1,1-disubstituted cyclopropane derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-03 EP claimed
EP-0237917-A2 1,1-Disubstituted cyclopropane derivatives, processes for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-23 EP claimed
US-20250257076-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXYLIC ACID DERIVATIVES AS cGAS INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2025-08-14 US disclosed
US-20250195536-A1 BICYCLOOCTANE KRAS INHIBITORS INCYTE CORP (US) 2025-06-19 US disclosed
WO-2025088073-A1 HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2025-05-01 WO disclosed
EP-4545138-A1 HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2025-04-30 EP disclosed
US-20240352037-A1 HETEROAROMATIC MACROCYCLIC ETHER CHEMOTHERAPEUTIC AGENTS NUVALENT, INC. 2024-10-24 US disclosed
WO-2024151833-A1 SPIRO DERIVATIVES AS M4 ACTIVATORS/MODULATORS AND USES THEREOF CEREVEL THERAPEUTICS, LLC (US) 2024-07-18 WO disclosed
WO-2024141757-A1 LSD1 MODULATORS EXSCIENTIA AI LIMITED (GB) 2024-07-04 WO disclosed
WO-2024091489-A1 FUSED AZINES AS DYNAMIN-1-LIKE PROTEIN INHIBITORS AND USES THEREOF MITOBRIDGE, INC. (US) 2024-05-02 WO disclosed
WO-2024086814-A2 CYCLIN INHIBITORS CIRCLE PHARMA, INC. (US) 2024-04-25 WO disclosed
US-5364989-A Reaction of vinylidene chloride with nitric acid and hydrogen chloride TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-11-15 US disclosed
CN-1069882-A The Compounds and methods for that suppresses HIV and correlated virus MEDIVIR AB (CH) 1993-03-17 CN disclosed
EP-0435151-A2 Process for the preparation of 1,1-disubstituted cyclopropane derivatives HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-03 EP disclosed
EP-0395175-A2 Thiazole derivatives SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1990-10-31 EP disclosed
EP-0381130-A2 Production of alpha-unsaturated amines Takeda Chemical Industries, Ltd. (JP) 1990-08-08 EP disclosed
US-4870088-A ANIMALS AND PLANTS HOECHST AKTIENGESELLSCHAFT (DE) 1989-09-26 US disclosed
EP-0237917-A2 1,1-Disubstituted cyclopropane derivatives, processes for their preparation and their use HOECHST AKTIENGESELLSCHAFT (DE) 1987-09-23 EP disclosed
US-4665066-A BACTERICIDES ELI LILLY AND COMPANY (US) 1987-05-12 US disclosed
EP-0000478-B1 PROCESS FOR THE PREPARATION OF ACYLOINS Henkel Kommanditgesellschaft auf Aktien (DE) 1981-11-25 EP disclosed